Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2017 | ASL MRI as an early biomarker for Alzheimer’s disease

M. Hale Alpsan Gökmen • 24 Jun 2017
EAN 2017
Alzheimer’s Disease

M. Hale Alpsan Gökmen, MD from the Anadolu Health Center, Gebze, Turkey discusses a study on arterial spin labeling (ASL) MRI as an early biomarker for Alzheimer’s disease. Dr Gökmen emphasizes the importance of diagnosing patients early and summarizes the findings of their study.
Recorded at the 2017 Congress of the European Academy of Neurology (EAN) in Amsterdam, the Netherlands.

Related Videos

3:58
Promising FONLISA test for ultrasensitive detection of plasma NfL in Alzheimer’s disease
Madison Honey • 7 Mar 2024
4:12
Updates in Alzheimer’s treatment: the potential of NSC001
Manfred Windisch • 6 Mar 2024
4:44
Influence of genetic risk for psychiatric disorders on dementia
Jenna Najar • 6 Mar 2024
2:06
The role of governments in addressing the access issues to dementia treatment
Paola Barbarino • 23 Mar 2024
The content of VJDementia is intended for healthcare professionals